FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports

Summary

Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.

Lotu Radar provides attributed news summaries and links to the original publisher. Full reporting and copyright remain with the source.